Safety and Efficacy of Insulin Aspart in Type 2 Diabetes
NCT01649570
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
123
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetes
Diabetes Mellitus, Type 2
Interventions
DRUG:
insulin aspart
Sponsor
Novo Nordisk A/S